
LSP closes Health Economics Fund on €112m
Dutch healthcare investor Life Sciences Partners (LSP) has held the final close of its Health Economics Fund (HEF) on €112m, exceeding its €100m target.
The fund launched in February 2012 and simultaneously held its first close with a large cornerstone investment, meaning HEF could immediately begin seeking investments.
The fund made its first investment in US company Illuminoss Medical. HEF co-led the business's $28m series-C funding round in September 2012.
The fund has a lifetime of 10 years with a five-year investment period. Terms and conditions for the vehicle are described as European standard by LSP HEF managing partner Rudy Dekeyser.
Investors
Prior to its first close, HEF received a €50m commitment from cornerstone investor Achmea, a Dutch healthcare insurance company. Another major investor in HEF is Dutch health insurer Menzis.
LSP began to target health insurance companies and family offices, the latter of which is described by Dekeyser as currently being very important to private equity, after interest from typical institutional investors, such as banks and pension funds, began to wane. Dekeyser said that the fundraising process began to accelerate quickly in the last three to four months, which allowed the fund to close above target.
The fund has also received commitments from French and German health insurers, as well as several large family offices and asset managers. Around €40m of the total amount was raised from family offices. The vehicle included a GP contribution.
The LPs for HEF were entirely from Europe, said Dekeyser, although the fund will invest in the US.
Investments
The fund will invest in European and US later-stage healthcare companies that have either commercialised their products or are very close to doing so.
HEF is different from LSP's other funds in that it will not invest in drug developing companies. It will focus its investments on companies that develop medical devices, diagnostics or healthcare-related IT solutions.
Around two thirds of the fund will be invested in European companies, with the balance going to US businesses. An investment in a European company is expected to be announced by LSP in the next couple of months.
People
Rudy Dekeyser is the managing partner for LSP HEF.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater